Biomedical subjects

Sang Jun Son

Publications and source records attributed to Sang Jun Son.

8 recordsLinked to original sources

PubMed2006

Controlled gold nanoparticle diffusion in nanotubes: Platfom of partial functionalization and gold capping.

Multifunctionality of nanotubes (NTs) is essential in biomedical and biotechnological applications, such as drug/gene delivery, bioseparation, and single-molecule detection. Each functionality should be located at optimal positions, depending on their roles such as targeting, tracking, and transporting. This enables avoidance of possible malfunctions or interference caused by having randomly distributed multiple groups (e.g., hydrophobic and hydrophilic) in the same space. In the aspect of multifunctionality, however, a general selective partial functionalization method of NT inner surfaces still remains a challenge. For this reason, we investigated a selective partial functionalization method of NTs using controlled gold nanoparticle (Au NP) diffusion in nanotubes and the preparation method of Au-capped silica nanotubes. Silica nanotubes (SNTs) were prepared using template sol-gel synthesis, and the inside of SNT was selectively modified with (3-trimethoxysilylpropyl) diethylenetriamine (DETA-silane). Au NPs of 2-nm size were then incubated with SNTs with DETA layer inside. Spontaneous diffusion of negatively charged Au NPs from bulk into the positively charged nanochannels of SNTs led trapped Au NPs onto the inner surface of SNTs. The degree of functionalization was controlled by the channel diameter, Au NP concentration, and solvent type. These SNTs partially modified with Au NPs were then used for localized selective chemical functionalization of SNTs. This was accomplished by the reaction between thionylated Au NPs trapped on the inside of SNTs and Alexa555-maleimide. Au-capped SNTs were prepared from SNTs with Au NPs inside by seed-mediated gold growth.

Diffusion↗

PubMed2006

Shape-coded silica nanotubes for biosensing.

Shape-coded silica nanotubes (SNTs) were fabricated on the basis of template synthesis as a new dispersible microarray system. The template synthesis of shape-coded SNTs begins with the fabrication of a porous alumina film that has well-defined cylindrical pores with two or more different diameter segments by multistep anodization of an aluminum substrate. Then, SNTs were fabricated with a surface sol-gel method that can control the wall thickness of SNTs on the single-nanometer level. Attractively, the difference in optical reflectance between the segmented parts of individual silica nanotube makes it very convenient to identify each nanotube and enables these shape-coded SNTs to work as coding materials for biosensing.

Biosensing Techniques↗

PubMed2006

Template synthesis of multifunctional nanotubes for controlled release.

In the past few decades, nanoscale materials have been widely used for controlled release applications. Importantly, many researches have focused on multifunctional nanoparticles for targeted delivery of bioactive and imaging agents as therapeutics and diagnostics. Recent advances in nanotechnology have made possible the design and development of tubular nanoscale particles called nanotubes. The tubular shape of such particles is highly attractive since it is possible to differentially functionalize the inner and outer surfaces to facilitate drug loading, biocompatibility and biorecognition. Novel synthetic strategies allow the fabrication of tubular structures with well-defined diameters and lengths. This can have important implications in biodistribution, subcellular trafficking and drug release. In this article the biomedical applications of nanotubes will be discussed with emphasis on the template synthesis of composite nanotubes containing silica and iron oxide that have potential use in drug delivery, magnetic resonance imaging (MRI), and chemical and biochemical separations.

Animals↗

PubMed2005

Observing capillarity in hydrophobic silica nanotubes.

The development of template-synthesized silica nanotubes has created a unique opportunity for studying confined fluids by providing nanometer-scale containers in which the inner diameter (i.d.) and surface chemistry can be systematically and independently varied. An interesting question to be answered is the following: do solvents wet nanometer-scale tubes in the same way they wet ordinary capillaries? To answer this question, we have conducted studies to explore the wettability of the hydrophobic interiors of individual nanotubes. In these studies, single nanotubes with i.d.'s of either 30 or 170 nm were investigated over a range of water/methanol mixtures. These studies provide a direct route for comparing wetting phenomena in nanotubes with conventional macroscopic theories of capillarity. Our observations reveal four important aspects of capillary wetting in the 30-170 nm regime, a size range where the application of the Young-Laplace theory has not been experimentally investigated for hydrophobic pores. They are (i) a sharp transition between wetting and nonwetting conditions induced by addition of a cosolvent, (ii) invariance of this transition between nanotubes of 30 and 170 nm pore diameter, (iii) failure of the Young-Laplace equation to accurately predict the cosolvent's (methanol) mol fraction where the transition occurs, and (iv) reversibility of the observed wetting. The first two aspects conform to conventional capillarity (Young-Laplace), but the latter two do not. These measurements were complemented with ensemble experiments. The difference between theory and experiment is likely due to reliance on macroscopic values of contact angles or to liquid-phase instability within the hydrophobic pore.

Journal Article↗

PubMed2005

Magnetic nanotubes for magnetic-field-assisted bioseparation, biointeraction, and drug delivery.

Tubular structure of nanoparticles is highly attractive due to their structural attributes, such as the distinctive inner and outer surfaces, over conventional spherical nanoparticles. Inner voids can be used for capturing, concentrating, and releasing species ranging in size from large proteins to small molecules. Distinctive outer surfaces can be differentially functionalized with environment-friendly and/or probe molecules to a specific target. Magnetic particles have been extensively studied in the field of biomedical and biotechnological applications, including drug delivery, biosensors, chemical and biochemical separation and concentration of trace amounts of specific targets, and contrast enhancement in magnetic resonance imaging (MRI). Therefore, by combining the attractive tubular structure with magnetic property, the magnetic nanotube (MNT) can be an ideal candidate for the multifunctional nanomaterial toward biomedical applications, such as targeting drug delivery with MRI capability. Here, we successfully synthesized magnetic silica-iron oxide composite nanotubes and demonstrated the magnetic-field-assisted chemical and biochemical separations, immunobinding, and drug delivery.

Animals↗

PubMed2003

Toward protein-cleaving catalytic drugs: artificial protease selective for myoglobin.

A protein-cleaving catalyst highly selective for a disease-related protein can be used as a catalytic drug. As the first protein-cleaving catalyst selective for a protein substrate, a catalyst for myoglobin (Mb) was designed by attaching the Cu(II) or Co(III) complex of cyclen to a binding site searched by a combinatorial method using peptide nucleic acid monomers as building units. Various linkers were inserted between the catalytic Co(III) center and the binding site of the Mb-cleaving catalyst. Kinetic data revealed catalytic turnover of the Mb cleavage by the Cu(II) or Co(III) complex. MALDI-TOF MS revealed cleavage of the polypeptide backbone of Mb at selected positions. N-Terminal sequencing of the cleavage products identified the cleavage site and provided evidence for the hydrolytic nature of the Mb cleavage. Various chelating ligands were tested as the ligand for the Co(III) center of the Mb-cleaving catalyst. Among the nine chelating ligands examined, only cyclen and its triaza-monooxo analogue manifested catalytic activity.

Binding Sites↗

PubMed2002

Protein-cleaving catalyst selective for protein substrate.

A protein-cleaving catalyst specific for a disease-related protein can be used as a catalytic drug. As the first protein-cleaving catalyst selective for a protein substrate, a catalyst for myoglobin was designed by attaching Cu(II) or Co(III) complex of cyclen to a binding site searched by a combinatorial method using peptide nucleic acid monomers as building units. [reaction: see text]

Base Sequence↗

PubMed1998

Kinetics of Hydrolysis of Phenyl Acetates Catalyzed by the Zinc(II) Complex of 1,5,9-Triazacyclododecane. Evidence for Attack of Water or Hydroxide Ion at the Coordinated Ester.

Rates for hydrolysis of substituted phenyl acetates were measured in the presence of the Zn(II) complex of 1,5,9-triazacyclododecane. The kinetic data are incompatible with the mechanism in which the water and hydroxide ion coordinated to the metal center makes a nucleophilic attack at the ester linkage. Instead, the results support the mechanism in which the ester is first complexed to the metal center and then water or hydroxide ion makes a nucleophilic attack at the complexed ester. The kinetic data further indicate that the electrostatic interaction between the cationic metal center and the anionic hydroxide ion facilitates the attack of hydroxide ion at the complexed ester. In addition, the C-O bond of the ester is not cleaved significantly in the rate-determining transition state for attack by both water and hydroxide ion.

Journal Article↗